Connect with us
The current round has an investment commitment of up to €3 million, which includes the participation of the founding partners. The €7 million will make it...
In 2022, Better Care reached a turnover of €1 million, compared to half a million euros it achieved in 2021. By 2023, the Catalan biotech company...
Looking ahead to 2024, the group plans to reach break-even, when the European Medicines Agency approves its drug against glioblastoma, an aggressive type of cancer that...
ReHand became the first digital solution via tablet for the rehabilitation of wrist, hand, and fingers, which account for 29% of the injuries that reach hospital...
VB Devices closed 2021 with sales of $339,000 (€315,000), the target for 2022 is to achieve $977,000 (€909,000) and for 2023 to exceed $1.6 million (€1.5...
Of the total amount that Laminar Pharma estimates it needs, $10.7 million (€10 million) correspond to bank financing already agreed with Banca March. In addition, the...
With the publication of the results of this trial, which will probably take place in March or April, Neurofix Pharma will increase its valuation and will...
Endolipid Therapeutics has developed a peptide platform. With this round, the company aims to cover development costs during 2022 to reach two milestones: licensing the anti-cellulite...
As a result of the campaign's success, MJN-neuro has decided to extend the campaign for more than 50 days to raise more funds and to have...
Corify Care has recently closed a financing round during which it raised $2.7 million (€2.3 million). The Spanish company, which is developing a non-invasive cardiac mapping...